Oct 3, 2021 | International
Drummondville, Quebec – Correctional Service Canada
Between September 14 and 16, 2021, as a result of the vigilance of staff members, several separate packages containing contraband and unauthorized items were seized at the Drummond Institution, a federal medium security facility.
The contraband and unauthorized items seized included 306 grams of hashish, four grams of cannabis resin, 50 tablets of amphetamine, 26 ecstasy pills, three cellphones, one SIM card and 1076 grams of tobacco. The total estimated institutional value of this seizure is $72,520.
The Correctional Service of Canada (CSC) uses a number of tools to prevent drugs from entering its institutions. CSC is heightening measures to prevent contraband from entering its institutions in order to help ensure a safe and secure environment for everyone. CSC also works in partnership with the police to take action against those who attempt to introduce contraband into correctional institutions.
CSC has also set up a telephone tip line for all federal institutions so that it may receive additional information about activities relating to security at CSC institutions. These activities may be related to drug use or trafficking that may threaten the safety and security of visitors, inmates and staff members working at CSC institutions.
The toll-free number, 1‑866‑780‑3784, helps ensure that the information shared is protected and that callers remain anonymous.
-30-
Elyse Sullivan
Acting Assistant Warden, Management Services
Drummond Institution
(819) 477-5112
Aug 3, 2021 | Business
Eisai Co., Ltd. announced today that its in-house discovered and developed anti-epileptic drug (AED) Fycompa (generic name: perampanel) has obtained two additional approvals as “a monotherapy for partial-onset seizures” and “an adjunctive treatment / a monotherapy for pediatric indication for partial onset seizures in patients with epilepsy 4 years of age and older” in China from the National Medical Products Administration.
Fycompa has already been approved in China as an adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 12 years of age and older. Through this approval, Fycompa is now available in China as a monotherapy and an adjunctive treatment for partial-onset seizures (with or without secondarily generalized seizures) in patients with epilepsy 4 years of age and older.
The approval covering monotherapy for partial-onset seizures was based on subgroup analysis estimating monotherapy safety and efficacy within clinical studies of Fycompa as adjunctive therapy (Study 304, 305, 306, and 335) conducted globally including the United States, Europe and China on patients ages 12 years and older with partial-onset seizures (with or without secondarily generalized seizures). Additionally, results of a Phase III clinical study (FREEDOM/Study 342) conducted in Japan and South Korea on untreated epilepsy patients ages 12 years to 74 years old with partial-onset seizures (with or without secondarily generalized seizures) were submitted as supplementary safety and efficacy data of Fycompa as monotherapy.
The approval covering partial-onset seizures in pediatric patients was based on the results of a Phase III clinical study (Study 311) of Fycompa as adjunctive therapy conducted globally on pediatric patients (ages 4 to less than 12 years) with inadequately controlled partial-onset seizures or primary generalized tonic-clonic seizures.
In China, it is estimated that there are approximately 9 million patients with epilepsy, and although onset occurs at any age, onset is most common in people aged 18 and younger and the elderly. As approximately 30% of patients with epilepsy are unable to control their seizures with currently available AEDs1, this is a disease with significant unmet medical needs.
Fycompa is a first-in-class AED and a once-daily tablet discovered at Eisai’s Tsukuba Research Laboratories. The agent is a highly selective, noncompetitive AMPA receptor antagonist that reduces neuronal hyper-excitation associated with seizures by targeting glutamate activity at AMPA receptors on postsynaptic membranes.
Eisai considers neurology, including epilepsy, a therapeutic area of focus. With this approval for Fycompa as a monotherapy and pediatric indication for patients with epilepsy 4 years or older in China, Eisai will continue to prioritize the provision of safety information, and pursue its mission to provide “seizure freedom” to a greater number of patients with epilepsy across the world. Eisai seeks to address the diverse needs of, as well as increase the benefits provided to, patients with epilepsy and their families.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
For more information, visit https://www.eisai.com/news/2021/news202166.html.
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Aug 1, 2021 | International
Agassiz, British Columbia – Correctional Service Canada
Between May 19 and July 27, 2021, as a result of the vigilance of staff members, contraband and unauthorized items were seized at Kent Institution, a maximum security institution.
The contraband and unauthorized items seized include the follow
May 19, 2021: Contents sent to the Royal Canadian Mounted Police (RCMP) for further analysis (estimated institutional value to be determined);
June 27, 2021: 1 ounce of THC butter, 1 bale of tobacco, 4 USB readers, and sim cards (estimated institutional value $8,000);
July 16, 2021: 52 nicotine patches and 3.5 grams marijuana (estimated institutional value to be determined);
July 17, 2021: 2 cell phones, 2 stabbing weapons, 30 grams of crystal methamphetamines, and remnants of an unmanned air vehicle (estimated institutional value $15,000);
July 20, 2021: Remnants of an unmanned air vehicle (estimated institutional value to be determined);
July 22, 2021: 1 bale of tobacco, 2 grams of marijuana, 15 grams of crystal methamphetamines, 27.9 grams of shatter, 2 Micro SD chargers, and an unidentified powder (estimated institutional value to be determined);
July 27, 2021: 10 grams of cocaine, 41 grams of crystal methamphetamines, and 4 packages of THC butter product (estimated institutional value $25,000).
The current estimated institutional value of these seizures is $48,000. The remaining contents that have not yet been valued are currently undergoing analysis by our partners at the RCMP.
The Correctional Service of Canada (CSC) uses a number of tools to prevent drugs from entering its institutions. These tools include ion scanners and drug-detector dogs to search buildings, personal property, inmates, and visitors.
CSC is heightening measures to prevent contraband from entering its institutions in order to help ensure a safe and secure environment for everyone. CSC also works in partnership with the police to take action against those who attempt to introduce contraband into correctional institutions.
CSC has set up a telephone tip line for all federal institutions so that it may receive additional information about activities relating to security at CSC institutions. These activities may be related to drug use or trafficking that may threaten the safety and security of visitors, inmates, and staff members working at CSC institutions.
The toll-free number, 1‑866‑780‑3784, helps ensure that the information shared is protected and that callers remain anonymous.
-30-
Kim MacPherson
Assistant Warden Management Services
Kent Institution
604-796-4567
